The Routine Use of SSRI's at the Initiation of End-stage Renal Disease Treatment (RoSIE)
Status:
Terminated
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
In this study the investigators hypothesize that antidepressant therapy may improve the
overall welling of patients with acute or chronic kidney disease when given around the time
of starting chronic dialysis therapy. This study is a pilot, randomized controlled trial that
aims to examine whether prescribing oral escitalopram to all incident dialysis patients is
safe and feasible.
Phase:
Phase 2
Details
Lead Sponsor:
University Health Network, Toronto
Collaborators:
McMaster University St. Michael's Hospital, Toronto Unity Health Toronto University of Toronto